30LBA A Phase 1 dose escalation, safety, and pharmacokinetic study of PF-06650808, an anti-Notch3 antibody drug conjugate, in adult patients with advanced solid tumors. (September 2015) - Rosen, L.S.; Wesolowski, R.; Gibson, B.; Baffa, R.; Liao, K.H.; Masters, J.; Hua, S.Y.; Deng, S.; Shazer, R.; Tolcher, A.W.